Literature DB >> 33398639

Inhibition of the Vesicular Glutamate Transporter (VGLUT) with Congo Red Analogs: New Binding Insights.

David M Hitt1,2, Jeffery D Zwicker1,3, Chih-Kai Chao1, Sarjubhai A Patel1, John M Gerdes1, Richard J Bridges1, Charles M Thompson4.   

Abstract

The vesicular glutamate transporter (VGLUT) facilitates the uptake of glutamate (Glu) into neuronal vesicles. VGLUT has not yet been fully characterized pharmacologically but a body of work established that certain azo-dyes bearing two Glu isosteres via a linker were potent inhibitors. However, the distance between the isostere groups that convey potent inhibition has not been delineated. This report describes the synthesis and pharmacologic assessment of Congo Red analogs that contain one or two glutamate isostere or mimic groups; the latter varied in the interatomic distance and spacer properties to probe strategic binding interactions within VGLUT. The more potent inhibitors had two glutamate isosteres symmetrically linked to a central aromatic group and showed IC50 values ~ 0.3-2.0 μM at VGLUT. These compounds contained phenyl, diphenyl ether (PhOPh) or 1,2-diphenylethane as the linker connecting 4-aminonaphthalene sulfonic acid groups. A homology model for VGLUT2 using D-galactonate transporter (DgoT) to dock and identify R88, H199 and F219 as key protein interactions with Trypan Blue, Congo Red and selected potent analogs prepared and tested in this report.

Entities:  

Keywords:  Congo red analogs; Docking; Inhibitor; Isostere; VGLUT; Vesicular glutamate transporter

Mesh:

Substances:

Year:  2021        PMID: 33398639      PMCID: PMC7904594          DOI: 10.1007/s11064-020-03182-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

Review 1.  The essence of excitation.

Authors:  R J Reimer; R T Fremeau; E E Bellocchio; R H Edwards
Journal:  Curr Opin Cell Biol       Date:  2001-08       Impact factor: 8.382

Review 2.  Organic anion transport is the primary function of the SLC17/type I phosphate transporter family.

Authors:  Richard J Reimer; Robert H Edwards
Journal:  Pflugers Arch       Date:  2003-06-17       Impact factor: 3.657

Review 3.  Neurotransmitter transporters: why dance with so many partners?

Authors:  Marco I González; Michael B Robinson
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

4.  Synaptic vesicles are capable of synthesizing the VGLUT substrate glutamate from α-ketoglutarate for vesicular loading.

Authors:  Kouji Takeda; Atsuhiko Ishida; Kento Takahashi; Tetsufumi Ueda
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

5.  Vesicular glutamate transporters use flexible anion and cation binding sites for efficient accumulation of neurotransmitter.

Authors:  Julia Preobraschenski; Johannes-Friedrich Zander; Toshiharu Suzuki; Gudrun Ahnert-Hilger; Reinhard Jahn
Journal:  Neuron       Date:  2014-11-26       Impact factor: 17.173

Review 6.  VGLUTs: 'exciting' times for glutamatergic research?

Authors:  Shigeo Takamori
Journal:  Neurosci Res       Date:  2006-06-09       Impact factor: 3.304

Review 7.  Glutamate transporters as drug targets.

Authors:  Eiichi Hinoi; Takeshi Takarada; Yuriko Tsuchihashi; Yukio Yoneda
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-04

8.  Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient.

Authors:  H Wolosker; D O de Souza; L de Meis
Journal:  J Biol Chem       Date:  1996-05-17       Impact factor: 5.157

Review 9.  Glutamatergic chemical transmission: look! Here, there, and anywhere.

Authors:  Yoshinori Moriyama; Akitsugu Yamamoto
Journal:  J Biochem       Date:  2004-02       Impact factor: 3.387

10.  Metabolic control of vesicular glutamate transport and release.

Authors:  Narinobu Juge; John A Gray; Hiroshi Omote; Takaaki Miyaji; Tsuyoshi Inoue; Chiaki Hara; Hisayuki Uneyama; Robert H Edwards; Roger A Nicoll; Yoshinori Moriyama
Journal:  Neuron       Date:  2010-10-06       Impact factor: 18.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.